Correction: Hydrophobic Carbon Dots Prevent α-Synucleinopathy and Suppress Neuroinflammation to Treat Parkinson's Disease

Lihua Li , Yao Lu , Xiangling Ye , Chi Zhang , Jialin Liu , Zhongmin Yang , Jianhua Hao

Aggregate ›› 2025, Vol. 6 ›› Issue (11) : e70202

PDF
Aggregate ›› 2025, Vol. 6 ›› Issue (11) :e70202 DOI: 10.1002/agt2.70202
CORRIGENDUM
Correction: Hydrophobic Carbon Dots Prevent α-Synucleinopathy and Suppress Neuroinflammation to Treat Parkinson's Disease
Author information +
History +
PDF

Abstract

The aggregation of α-synuclein (ɑ-syn) coupled with overexpressed neuroinflammation instigates the degeneration of dopaminergic neurons, thereby aggravating the progression of Parkinson's disease (PD). Herein, we introduced a series of hydrophobic amino acid-based carbon dots (CDs) for inhibiting ɑ-syn aggregation and mitigating the inflammation in PD neurons. Significantly, we show that phenylalanine CDs (Phe-CDs) could strongly bind with ɑ-syn monomers and dimers via hydrophobic force, maintain their stability, and inhibit their further aggregation in situ and in vitro, finally conferring neuroprotection in PD by rescuing synaptic loss, ameliorating mitochondrial dysfunctions, and modulating Ca2+ flux. Importantly, Phe-CDs demonstrate the ability to penetrate the blood–brain barrier, significantly improving motor performance in PD mice. Our findings suggest that Phe-CDs hold great promise as a therapeutic agent for PD and the related neurodegenerative disease.

Keywords

amino acid / carbon dots / neuroinflammation / Parkinson's disease / α-synuclein aggregation

Cite this article

Download citation ▾
Lihua Li, Yao Lu, Xiangling Ye, Chi Zhang, Jialin Liu, Zhongmin Yang, Jianhua Hao. Correction: Hydrophobic Carbon Dots Prevent α-Synucleinopathy and Suppress Neuroinflammation to Treat Parkinson's Disease. Aggregate, 2025, 6(11): e70202 DOI:10.1002/agt2.70202

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

2025 The Author(s). Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.

PDF

3

Accesses

0

Citation

Detail

Sections
Recommended

/